[Post-mortem evaluation in endemic pemphigus foliaceus and pemphigus vulgaris].

Authors: Aki HE,Sotto MN,Sampaio SA,
Address:
Journal: Med Cutan Ibero Lat Am.

Publication: 1984;12(2):151-7.

abstract

Eighteen autopsies were performed in patients with pemphigus that died during treatment between 1961 and 1981. Eight of these patients had endemic pemphigus foliaceus and ten had pemphigus vulgaris. The pemphigus vulgaris patients were receiving only corticosteroids while some of those with pemphigus vulgaris also received immunosuppressors. Side effects from the medication were a major contributing factor in the death of 7 of the 8 pemphigus foliaceus patients and in 8 of the 10 cases of pemphigus vulgaris. The causa mortis to which the medication contributed to was strongyloidiasis in 4 patients, disseminated septicemia in 3 patients, bronchial pneumonia in 3 patients, miliary tuberculosis in 2 patients, massive gastrointestinal hemorrhage, pulmonary infarct and balantidiasis with strongyloidiasis in 1 patient each. The authors stress the need for careful investigation of strongyloidiasis and eradication by treatment not only when starting but also during therapy with large doses of corticosteroids and cytotoxic agents.

Related Articles
Treatment of pemphigus vulgaris and pemphigus foliaceus: experience with 71 patients over a 20 year period.
Rev Inst Med Trop Sao Paulo. 2001
Treatment of pemphigus vulgaris and pemphigus foliaceus: experience with 71 patients over a 20 year period.
Fernandes NC, Perez M. Rev Inst Med Trop Sao Paulo. 2001 Jan-Feb; 43(1):33-6.
[A clinical analysis of 64 cases of pemphigus].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1998
[A clinical analysis of 64 cases of pemphigus].
He Z, Wang B, Yu B. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1998 Apr; 20(2):144-7.
Treatment of pemphigus vulgaris and pemphigus foliaceus with mycophenolate mofetil.
Arch Dermatol. 2003
Treatment of pemphigus vulgaris and pemphigus foliaceus with mycophenolate mofetil.
Mimouni D, Anhalt GJ, Cummins DL, Kouba DJ, Thorne JE, Nousari HC. Arch Dermatol. 2003 Jun; 139(6):739-42.
Review [Treatment of severe refractory pemphigus vulgaris with rituximab].
Actas Dermosifiliogr. 2006
Review [Treatment of severe refractory pemphigus vulgaris with rituximab].
Pitarch G, Sánchez-Carazo JL, Pardo J, Torrijos A, Roche E, Fortea JM. Actas Dermosifiliogr. 2006 Jan-Feb; 97(1):48-51.
Review Mortality associated with concurrent strongyloidosis and cytomegalovirus infection in a patient on steroid therapy.
Mt Sinai J Med. 1999
Review Mortality associated with concurrent strongyloidosis and cytomegalovirus infection in a patient on steroid therapy.
Wang BY, Krishnan S, Isenberg HD. Mt Sinai J Med. 1999 Mar; 66(2):128-32.
Endemic pemphigus foliaceus over a century: Part I.
N Am J Med Sci. 2010
Endemic pemphigus foliaceus over a century: Part I.
Abréu-Vélez AM, Reason IJ, Howard MS, Roselino AM. N Am J Med Sci. 2010 Feb; 2(2):51-9.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.